Dr. Paul Nugent

Sleep Medicine
The Christ Hospital Urgent Care Center
4440 Red Bank Rd Ste 110, 
Cincinnati, OH 
The Christ Hospital Urgent Care Center
4440 Red Bank Rd Ste 110, 
Cincinnati, OH 

Overview

Paul Nugent is a primary care provider, practicing in Sleep Medicine in Cincinnati, Ohio. His top areas of expertise are Chronic Pain, Neuralgia, Severe Acute Respiratory Syndrome (SARS), and Osteoarthritis.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 15 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Sleep Medicine

Licenses

Family Medicine in OH

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

The Christ Hospital Urgent Care Center
4440 Red Bank Rd Ste 110, Cincinnati, OH 45227

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

15 Clinical Trials

A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
Enrollment Status: Completed
Publish Date: August 15, 2025
Intervention Type: Drug, Biological
Study Drug: Mepolizumab
Study Phase: Phase 3
A Phase 3, Randomized, Placebo-controlled, Observer-blind, Multi-country Study to Demonstrate the Efficacy of a Single Dose and Annual Revaccination Doses of GSK's RSVPreF3 OA Investigational Vaccine in Adults Aged 60 Years and Above
A Phase 3, Randomized, Placebo-controlled, Observer-blind, Multi-country Study to Demonstrate the Efficacy of a Single Dose and Annual Revaccination Doses of GSK's RSVPreF3 OA Investigational Vaccine in Adults Aged 60 Years and Above
Enrollment Status: Completed
Publish Date: July 31, 2025
Intervention Type: Biological
Study Drug: RSVPreF3
Study Phase: Phase 3
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Enrollment Status: Completed
Publish Date: July 17, 2024
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Enrollment Status: Completed
Publish Date: November 30, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Completed
Publish Date: November 22, 2023
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Osteoarthritis
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Osteoarthritis
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis Pain
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Terminated
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
View 9 Less Clinical Trials

1 Total Publications

Why have so many African leaders died of COVID-19?
Why have so many African leaders died of COVID-19?
Journal: BMJ global health
Published: March 04, 2021
Similar Doctors
Expertise in
14
conditions
Dr. Narong Simakajornboon
Sleep Medicine
Expertise in
14
conditions
Dr. Narong Simakajornboon
Sleep Medicine

Cincinnati Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (6.2 miles away)
513-636-6771
Languages Spoken:
English
See accepted insurances

Narong Simakajornboon is a Sleep Medicine provider in Cincinnati, Ohio. Dr. Simakajornboon is highly rated in 14 conditions, according to our data. His top areas of expertise are Laryngomalacia, Central Sleep Apnea, Obstructive Sleep Apnea, Infantile Apnea, and Adenoidectomy.

Stacey Ishman
Expertise in
12
conditions
Dr. Stacey Ishman
Sleep Medicine
Expertise in
12
conditions
Dr. Stacey Ishman
Sleep Medicine

Cincinnati Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (6.2 miles away)
513-636-4355
Languages Spoken:
English
See accepted insurances

Stacey Ishman is a Sleep Medicine provider in Cincinnati, Ohio. Dr. Ishman is highly rated in 12 conditions, according to our data. Her top areas of expertise are Obstructive Sleep Apnea, Laryngomalacia, Mastoiditis, Adenoidectomy, and Glossectomy.

Expertise in
25
conditions
Dr. Thomas Dye
Sleep Medicine
Expertise in
25
conditions
Dr. Thomas Dye
Sleep Medicine

Cincinnati Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (6.2 miles away)
513-636-4222
Languages Spoken:
English
See accepted insurances

Thomas Dye is a Sleep Medicine provider in Cincinnati, Ohio. Dr. Dye is highly rated in 25 conditions, according to our data. His top areas of expertise are Periodic Limb Movement Disorder, Narcolepsy, Restless Legs Syndrome, Excessive Daytime Sleepiness, and Adenoidectomy.

Frequently Asked Questions about Dr. Paul Nugent

How do I make an appointment with Dr. Paul Nugent?

You can book an appointment with Dr. Paul Nugent by calling their office at 513-564-1366. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Paul Nugent a top-rated expert for Chronic Pain?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Paul Nugent is classified as an Experienced expert for Chronic Pain, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Paul Nugent specialize in?

While Dr. Paul Nugent is a Sleep Medicine, they have specific expertise in Chronic Pain, Neuralgia, and Severe Acute Respiratory Syndrome (SARS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Sleep Medicine.

Does Dr. Paul Nugent participate in research or clinical trials?

Yes. Dr. Paul Nugent has published 1 articles and abstracts on conditions like Chronic Pain. You can view a list of Dr. Paul Nugent's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nugent's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile